Comment on “Non-hepatitis virus-associated mixed essential cryoglobulinemia”  by Kirmizis, Dimitrios A. et al.
In their case 1 (p 1244), they report on ‘a 27-year-old
woman with type 1 diabetes mellitus y brought to the
emergency department with obtundation and severe
hyperpnea y’; her blood pH is 7.05, PaCO2 15mmHg
and standardized base excess 25mEq/l. The therapeutic
recommendation is a platonic ‘to reverse the organic
acidosis’.
According to Edge et al.,2 low blood pH (which implies a
high concentration of hydrogen ions Hþ ) is the cause of
decreased level of consciousness. The glycolytic enzyme
phosphofructokinase is pH dependent,3 as its activity
decreases with decreasing pH and thus, glucose utilization
in the brain cells is impaired. Therefore, the clinical
consequences of decreasing blood pH are drowsiness, stupor,
coma, and death in coma. In the reported obtunded woman,
the immediate cause of obtundation is her very low blood pH
of 7.05, regardless of which of the three discussed approaches
is the most useful. To avoid further deterioration of the
obtundation to frank coma (potentially lethal), it would be
necessary to administer alkalizing solutions intravenously as
soon as possible, to increase and normalize the low blood pH.
This has been life-saving also in desperate situations (e.g.,
Kamarzaman et al.4).
In their case 2 (p 1244), they report on ‘a 58-year-old man
with advanced chronic obstructive pulmonary disease and
congestive heart failurey. His medications includey diuretics’;
his blood pH is 7.41, PaCO2 58mmHg, standardized base excess
11mEq/l and Kþ 3.2mEq/l. The authors write on ‘metabolic
alkalosis (diuretic induced)’, and their recommendation is to
‘reduce the metabolic component and thus the blood pH by
administering potassium chloride’. Thus, they admit that the
cause of metabolic alkalosis is low blood potassium (3.2mEq/l).
When we assess acid–base disorders, it would be useful to say
simply that this patient is ‘hypokalemic alkalosis’, again regardless
of which of the discussed approaches is the most useful.
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The Authors Reply: We thank Dr Rosival for his letter.1
However important his points might be, they are unrelated to
the central focus of our paper.2 As the title of our paper
indicates, our aim was to evaluate the existing approaches to
assessing acid–base disorders.
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Comment on ‘‘Non-hepatitis
virus-associated mixed essential
cryoglobulinemia’’
To the Editor: We read with interest the instructive case of
non-hepatitis virus-associated mixed essential cryoglobuline-
mia reported by Annear et al.1 The search for a situation
underlying, accompanying, or preceding a glomerulonephritis
can often be intriguing or puzzling, especially when it is
regarding a latent, quiescent, or multiphasic viral infection
presenting with a nonspeciﬁc clinical syndrome, such as in
the presented case. Are serological tests alone adequate for
the diagnosis of an acute infection and the connection of a
glomerulonephritis to the corresponding infection? There are
infections, such as parvovirus infections, wherein even the
immunoglobulin M levels are maintained high for several
months after the acute infection.2,3 This ﬁnding restricts their
diagnostic value and, therefore, one should be cautious in
their interpretation for the diagnosis of the acute phase of
infections. In this particular case, the diagnosis of acute
parvovirus infection was made on the basis of the positive
serological test. In such cases, the use of polymerase chain
reaction test for the detection of viral nucleic acid, although
lacks validation for many infections, can provide more solid
answers regarding the diagnosis of an acute infection.
Although one cannot rule out the possibility that parvovirus
infection might have triggered the production of cryoglobu-
lins, the presumed association of the cryoglobulinemic
glomerulonephritis with parvovirus B19 infection needs a
more careful dissection, as long as no etiological connection
between the two entities has been documented in this case;
moreover, unlike hepatitis C virus-related cryoglobulinemia,
cryoglobulin was not found to be directed against parvovirus.
From a clinical standpoint, this is not surprising, as long as it
is known that chronic rather than acute infections usually
lead to clinically signiﬁcant cryoglobulinemia. Furthermore,
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it was shown earlier that speciﬁc immunoglobulin G antibodies
to parvovirus B19 are found in the majority of essential mixed
cryoglobulinemia cases, and that parvovirus infection is
rather not implicated in the pathogenesis of mixed cryoglo-
bulinemia.4 After all, the clinical syndrome in this case could
be rather attributed to cryoglobulinemia itself. In this context,
we believe that the title, as well as several points within the
paper trying to associate the glomerulonephritis with a
presumed acute parvovirus infection, might cause confusion
to the reader. In situ hybridization in the renal tissue could
provide more solid evidence regarding the probable causal
relation between the infection and cryoglobulinemic glomer-
ulonephritis.
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The Authors Reply: In their letter, Drs Kirmizis and
Chatzidimitriou1 highlight the difﬁculties in ascribing causality
for immune-mediated disease to an infectious agent. We
agree that there is no evidence that in the case we described
the cryoglobulin was secondary to acute parvovirus infection,
but it was most likely a coincidental infection.2 We are
conﬁdent that this was an acute infection as, unlike the
previous cases of anti-parvovirus IgG positivity in patients
with cryoglobulinemia,3 we conﬁrmed infection by perform-
ing parvovirus quantitative PCR that showed viral DNA in
the patient’s blood. Indeed this is why we investigated
the cryoprecipitate and showed that there was no increased
anti-parvovirus activity in the cryoprecipitate compared to
the serum.
The title of our article sought to highlight the fact that the
case was not secondary to hepatitis C or B infection and may
have better been entitled ‘non-viral hepatitis-associated
cryoglobulinemia’. In addition to our ﬁndings, data from
other centers suggest that in Northern European populations
mixed essential cryoglobulinemia is often not associated with
hepatitis C or B viral infections, in contrast to cases from
Southern Europe.4 Unlike parvovirus B19, hepatitis C virus is
capable of exerting a direct effect on B lymphocytes, lending a
pathophysiological link to the production of cryoglobulins.
The reason for the discrepancies in viral etiology between
different populations is interesting and we believe merits
further investigation, which may ultimately lead to the
discovery of another B-cell tropic cryoglobulin-inducing
stimulus.
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